Approval · Notice of Compliance 28576 · 2022
TRUSOPT: Notice of Compliance 28576
Issued July 12, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28576
- Date
- July 12, 2022
- Company
- Elvium Life SciencesToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph to the current 2020 PM Master Template and to align the inner and out labels with Plain Language Labelling (PLL) requirements
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRUSOPT | Not yet assigned | — |
| TRUSOPT PRESERVATIVE-FREE | Not yet assigned | — |
Medicinal ingredients
- DORZOLAMIDE HYDROCHLORIDE 20 MG per ML